Capital requirements for health insurance under Solvency II



Similar documents
Fifth Quantitative Impact Study of Solvency II (QIS5)

An update on QIS5. Agenda 4/27/2010. Context, scope and timelines The draft Technical Specification Getting into gear Questions

Solvency II Standard Model for Health Insurance Business

CEIOPS-DOC-43/09. (former CP 50) October 2009

SOLVENCY II HEALTH INSURANCE

CEIOPS-DOC-47/09. (former CP 55) October 2009

Solvency 2 Preparatory Phase. Comparison with LTGA specifications. June 2014

Fourth study of the Solvency II standard approach

CEIOPS-DOC-22/09. (former CP27) October CEIOPS e.v. Westhafenplatz Frankfurt Germany Tel

SOLVENCY II LIFE INSURANCE

Solvency II and catastrophe

Solvency II Introduction to Pillar 3. Friday 20 th May 2016

Solvency II Pillar III Quantitative Reporting Templates (QRTs) Sinead Clarke, Eoin King 11 th December 2012

Quantitative Impact Study 1 (QIS1) Summary Report for Belgium. 21 March 2006

Solvency ii: an overview. Lloyd s July 2010

SCOR inform - April Life (re)insurance under Solvency II

SOLVENCY II LIFE INSURANCE

SOLVENCY II HEALTH INSURANCE

The standard formula requires further adjustments

Implementation of Solvency II

Guidelines on undertaking-specific parameters

Solvency II for Beginners

International Financial Reporting for Insurers: IFRS and U.S. GAAP September 2009 Session 25: Solvency II vs. IFRS

CEIOPS-DOC-33/09. (former CP 39) October 2009

CEIOPS-DOC-45/09. (former CP 53) October 2009

Insurance Groups under Solvency II

Treatment of technical provisions under Solvency II

Solvency II overview

THE INSURANCE BUSINESS (SOLVENCY) RULES 2015

INVESTMENT FUNDS: Funds investments. KPMG Business DialogueS November 4 th 2011

Solvency II. Solvency II implemented on 1 January Why replace Solvency I? To which insurance companies does the new framework apply?

Introduction to Solvency II

Solvency II Technical Provisions valuation as at 31st december submission template instructions

CEIOPS-QIS5-06/10 6 September 2010

SA QIS3 Key changes and challenges The end is in sight

ORSA - The heart of Solvency II

Guidelines on the valuation of technical provisions

Guidelines on ring-fenced funds

Solvency II Standard Formula and NAIC Risk-Based Capital (RBC)

SOLVENCY II GENERAL INSURANCE

KPMG Business DialogueS

CEIOPS Advice for Level 2 Implementing Measures on Solvency II: Articles 120 to 126. Tests and Standards for Internal Model Approval

Preparing for ORSA - Some practical issues Speaker:

Revised Annexes to the Technical Specifications for the Solvency II valuation and Solvency Capital Requirements calculations (Part I)

Regulatory Solvency Assessment of Property/Casualty Insurance Companies in the United States

Solvency Assessment and Management Third South African Quantitative Impact Study (SA QIS3)

Consultation Paper on the Proposal for Guidelines on submission of information to national competent authorities

Health SLT risks for income protection insurance under Solvency II

Solvency II Standard Formula Exercise Guidance Notes. February 2014

Impacts of the Solvency II Standard Formula on health insurance business in Germany

Regulations in General Insurance. Solvency II

NST.06 - Non-life Insurance Claims Information - Detailed split by Distribution Channel and Claims Type.

EIOPACP 13/011. Guidelines on PreApplication of Internal Models

'SOLVENCY II': Frequently Asked Questions (FAQs)

Solvency II New Framework for Risk Management Organisation. Dr. Maciej Sterzynski (Triglav Insurance, Ltd.) Matija Bitenc (Triglav Insurance, Ltd.

ORSA for Insurers A Global Concept

Embedded Value Report

COMMISSION DELEGATED DECISION (EU) / of

Central Bank of Ireland Guidelines on Preparing for Solvency II Pre-application for Internal Models

EIOPA technical specifications for Long-Term Guarantee Assessment. January Milliman Solvency II Update

2015 No. 575 FINANCIAL SERVICES AND MARKETS. The Solvency 2 Regulations 2015

1. INTRODUCTION AND PURPOSE

CEIOPS-DOC-36/09. (former CP 42) October 2009

Méthode de provisionnement en assurance non-vie Solvency II & IFRS

Consequences. Modelling. Starting Points. Timetable. Solvency II. Solvency I vs Solvency II. Solvency I

Solvency II in practice. Speaker: Tim O Hanrahan Deputy Head, Insurance, Central Bank of Ireland 16 March 2016

Biljana Petrevska 1, PhD SOLVENCY II SUPERVISION OF THE INSURANCE UNDERTAKINGS RISK MANAGEMENT SYSTEMS. Abstract

The European solvency margin: an update for Italian non-life insurance companies

Life Insurance Corporation (Singapore)Pte Ltd UEN E MANAGEMENT REPORT 31/12/2014

SOLVENCY II Level 2 Implementing Measures

CEA Working Paper on the risk measures VaR and TailVaR

STATUTORY INSTRUMENTS. S.I. No. 485 of 2015 EUROPEAN UNION (INSURANCE AND REINSURANCE) REGULATIONS 2015

Solvency II. PwC. *connected thinking. Internal models requirements and an example

2. The European insurance sector

Implementation of Solvency II: The dos and the don ts

Feedback on the 2012 thematic review of technical provisions

Important note: This document is a working document of the Commission services for discussion. It does not purport to represent or pre-judge the

Gabriel Bernardino Chairman of EIOPA

Final Report. Public Consultation No. 14/036 on. Guidelines on application of outwards reinsurance. arrangements to the non-life

Non Life Insurance risk management in the Insurance company : CSOB case studies

Making it clear Reporting and disclosure in the Solvency II world

ORSA for Dummies. Institute of Risk Management Solvency II Group April 17th Peter Taylor

EIOPA-CP-11/008 7 November Consultation Paper On the Proposal for Guidelines on Own Risk and Solvency Assessment

Solvency II. Impacts on asset managers and servicers. Financial Services Asset Management.

The package of measures to avoid artificial volatility and pro-cyclicality

Transcription:

Capital requirements for health insurance under Solvency II Medical Expense Insurance: Actuarial Aspects and Solvency Afternoon Seminar at the AG Insurance Chair in Health Insurance, KU Leuven 25 April 2013

Solvency II Group supervision & cross-sectoral convergence Groups are recognised as an economic entity => supervision on a consolidated basis (diversification benefits, group risks) Pillar 1: quantitative requirements 1. Harmonised calculation of technical provisions 2. "Prudent person" approach to investments instead of current quantitative restrictions 3. Two capital requirements: the Solvency Capital Requirement (SCR) and the Minimum Capital Requirement (MCR) Pillar 2: qualitative requirements and supervision 1. Enhanced governance, internal control, risk management and own risk and solvency assessment (ORSA) 2. Strengthened supervisory review, harmonised supervisory standards and practices Pillar 3: prudential reporting and public disclosure 1. Common supervisory reporting 2. Public disclosure of the financial condition and solvency report (market discipline through transparency)

SCR standard formula Modules of the SCR standard formula Non-life underwriting risk Life underwriting risk Health underwriting risk Market risk Counterparty default risk "The health underwriting risk module shall reflect the risk arising from the underwriting of health insurance obligations, whether it is pursued on a similar basis to that of life insurance or not, following both from the perils covered and the process used in the conduct of business."

Definition and segmentation of health insurance Heterogeneity of the European health insurance market 27 different social systems and insurance traditions substitutive, supplementary or complementary large variety of medical services covered long-term or short term covering expenses or paying lump sums special features like premiums adjustments, risk equalisation Health Task Force in 2010 Members: supervisors, industry representatives, actuaries Worked on definition segmentation health risk equalisation systems

Definition and segmentation of health insurance Health insurance covers one or both of the following: The provision of medical treatment or care including preventive or curative medical treatment or care due to illness, accident, disability or infirmity, or financial compensation for such treatment or care Financial compensation for illness, accident, disability or infirmity Medical expense insurance (ME) Income protection insurance (IP) Workers' compensation insurance (WC) = health insurance relating to accidents at work, industrial injury and occupational disease.

Definition and segmentation of health insurance Non-life insurance obligations (NSLT Health) ME insurance * IP insurance * WC insurance ME prop. reinsurance * IP prop. reinsurance * WC prop. reinsurance Health nprop. reinsurance * excluding WC Life insurance obligations (SLT Health) Health insurance Annuities Health reinsurance

SCR standard formula

Health underwriting risk module Health NSLT Health SLT Health CAT Premium & Reserve Mortality Lapse Mass accident Lapse Longevity Expense Accident concentration Morbidity/ Disability Revision Pandemic

Premium and reserve risk SCR pr = 3 σ V multiplication by 3 corresponds to slightly skewed distribution of annual losses standard deviation of annual losses, normalised by volume measure volume measure V = V prem +V res

Calibration of standard deviations Non-life and NSLT health calibration controversial since QIS2 poor empirical justification For QIS5 larger calibration exercise of CEIOPS But data base and calibration methodology remain controversial 2010/2011 EIOPA Joint Working Group on Calibration Chaired by Peter ter Berg (Dutch National Bank) Involves supervisors, industry representatives and actuaries Mid-2011: new calibration proposal for non-life and NSLT health

Data basis Content of data sets: Earned premiums Claims triangles Ultimate loss estimates Expenses Gross/net of reinsurance; including/excluding CAT losses About 2700 data sets from insurers of 26 EEA member states

Insurers BE Insurers Countries Medical expenses 269 6 25 Income protection 381 6 24 Workers' compensation 51 5 16 NP reinsurance 8-6

Data limitations and data cleaning Automatic filters for data anomalies manual correction or exclusion of data Length of data series: min 3 years, confirmed by sensitivity analysis Insurers' data excluding CAT only usable for property insurance for other LoB manual removal of isolated peaks Data with outlying residuals removed Mainly use of data gross of reinsurance because sample of net data significantly smaller

Estimation process Step 1: Estimation of standard deviation per insurer Step 2: Modelling of size-dependent standard deviation Step 3: Derive calibration from the model

Step 1: Estimation of standard derivation per insurer Premium risk: Standard estimator applied to time series of combined ratios Reserve risk: Standard estimator applied to time series of run-off ratios Mean squared error of prediction (MSEP) Merz/Wüthrich: "Modelling The Claims Developement Result For Solvency Purposes"

Step 2: Modelling of size-dependent standard deviation Premium risk: Variance proportional to premiums or squared premiums or a mixture of both Lognormal distribution of annual loss Maximum likelihood estimation Reserve risk: Run-off ratios same model as for premium risk with best estimate as volume measure MSEP two approaches: Variance proportional to squared best estimate; least squares fitting Similar model as for premium risk with best estimate as volume measure

Step 3: Correction for sample bias Size bias of sample Larger insurers may be overrepresented in the sample Use of size distribution of QIS5 participants plus correction for missing small participants National market bias Some national markets may be better represented in the sample than others Average of country standard deviations, weighted with country market size

Example: Medical expense insurance premium risk

Step 3: Choice of relevant insurer size for calibration How many insurers should be below/above the relevant size? How many policyholders should belong to insurers below/above the relevant size? Median insurer size, but not more than 95% of policyholders should belong to insurers larger than the relevant size.

Results Medical expenses Income protection Workers' compensation NP reinsurance Premium risk Reserve risk QIS5 new QIS5 new 4% 5% 10% 5% 8.5% 9% 14% 14% 5.5% 8% 11% 11% 17% 17% 20% 20%

Impact assessment Change in SCR Medical expenses +5% Income protection ±0% Workers' compensation +15% NP reinsurance ±0% Premium and reserve risk +4% More details about the calibration on EIOPA's website: "Calibration of the Premium and Reserve Risk Factors in the Standard Formula of Solvency II"

Solvency Capital Requirement The SCR standard formula is not the last word! Recognition of health risk equalisation systems Undertaking-specific parameters Premium and reserve risk Revision risk Partial and full internal models Capital add-ons